Clinical Trial Update: A Study to Evaluate the Effect of HER2 Activation on rhuMAb 2C4 (Pertuzumab) in Subjects With Advanced Ovarian Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the effect of HER2 activation on Pertuzumab in subjects with advanced ovarian cancer; the study has completed and results have been pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Pertuzumab (pertuzumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-06-23